Home / SME Stocks / Avience Biomedicals
Avience Biomedicals: IPO, Share Price and Results Since Listing
Avience Biomedicals listed on NSE Emerge on 25 June 2026 after an IPO at INR 208 a share. On 11 November 2026 the shares closed at INR 262.40, 26.15% above the issue price. For H1 FY2027 it reported revenue of INR 31.13 crore and a profit after tax of INR 5.54 crore.
Key Facts
- IPO dates
- 18 June 2026 to 22 June 2026
- Issue price
- INR 208
- Issue size
- INR 30.24 crore
- Subscription
- 385.33 times
- Lead manager
- Fintellectual Corporate Advisors Private Limited
- Listing day
- opened at INR 395.20 (+90%), closed at INR 414.95 (+99.50%)
- Listed on NSE Emerge
- 25 June 2026
- Symbol
- AVIENCE
- Latest close
- INR 262.40 on 11 November 2026
- Against issue price
- +26.15%
- Lot size now
- 600 shares (INR 1,57,440 at the latest close)
Results Filed With NSE
Consolidated figures, INR crore. Change compares with the same period a year earlier.
| Period | Revenue | Change | Profit after tax | EPS (INR) | Filed | |
|---|---|---|---|---|---|---|
| H1 FY2027 | 31.13 | – | 5.54 | 10.10 | after listing | 10 November 2026 |
| H2 FY2026 | 25.69 | – | 4.21 | 10.45 | before listing | 26 August 2026 |
| FY2026 | 52.51 | – | 8.75 | 21.71 | before listing | 26 August 2026 |
Promoter Holding
Promoter holding has moved from 64.59% on 24 June 2026 to 64.59% on 30 September 2026 (0 percentage points).
| As of | Promoters | Public |
|---|---|---|
| 30 September 2026 | 64.59% | 35.41% |
| 24 June 2026 | 64.59% | 35.41% |
Anchor Lock-ins
| Lock-in | Ends |
|---|---|
| 30 days | 23 July 2026 |
| 90 days | 21 September 2026 |
Sources: NSE Emerge filings (results XBRL, shareholding pattern, board meetings), NSE daily price files, and IPO records. Prices are not adjusted for bonus issues or splits.